Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intervertebral disc is a fibrocartilaginous tissue sandwiched between vertebral bodies in the spine, composed of a tough outer ring (anulus fibrosus) made of type I collagen and a hydrated gelatinous center (nucleus pulposus) rich in type II collagen and aggrecan. Cartilaginous endplates cap the disc superiorly and inferiorly. The disc acts as a shock absorber, distributes compressive loads, enables flexibility, and prevents vertebral friction. It is mostly avascular in adults, receiving nutrients mainly by diffusion. Molecularly, the disc contains various cell types including chondrocyte-like cells, progenitor cells, and immune cells (especially in degenerative states). Disc degeneration is a key pathological process, associated with the loss of proteoglycans and water, increased oxidative stress, inflammation, and altered cell activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intervertebral disc.